Skip to main content
SpringerLink
Log in

Antineoplastics

Development of drug resistance: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cortiula F, et al. Non-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies. Anti-Cancer Drugs 33: 960-962, No. 9, Oct 2022. Available from: URL: http://doi.org/10.1097/CAD.0000000000001321

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1939, 49 (2023). https://doi.org/10.1007/s40278-023-31457-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-31457-x

Search

Navigation